MALVERN, Pa. -- Siemens Healthcare has announced that it recently submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for the MAMMOMAT Inspiration® with Breast Tomosynthesis option.
News Well, Press Release, Regulatory/Clearance, Breast Cancer, Food & Drug Administration (FDA), Mammography, Pre-Market Approval (PMA), Women's Health
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1m55x5u
Cap comentari:
Publica un comentari a l'entrada